Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET
Company Participants
Stephen Kilmer – IR
Jerome Wong – Chief Financial Officer
Scott Davis – Chief Executive Officer
Conference Call Participants
Li Chen – H.C. Wainwright
Ben Haynor – Lake Street Capital
Operator
Greetings, and welcome to the Ekso Bionics Fourth Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure, to introduce Stephen Kilmer. Thank you. You may begin.
Stephen Kilmer
Thank you, operator, and good afternoon, everyone. Earlier today, Ekso Bionics released financial results for the quarter and year ended December 31, 2024. A copy of the press release is available on our website.
I would like to point out that management will make statements during this call that include forward-looking statements within the meaning of the Federal Securities Laws, which are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not statements of historical facts shall be deemed to be forward-looking statements.
All forward-looking statements, including statements regarding our business strategy, future financial or operational expectations or our expectations of the regulatory landscape governing our products and operations, are based upon management’s current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements.
For a list and description of the risks and uncertainties associated with the company’s business, please see its filings with the Securities and Exchange Commission. Ekso
Read the full article here